Skip to main content
OpenTrials

Clinical trial condition

Genital Neoplasms, Female

Explore clinical trials studying Genital Neoplasms, Female. Study availability and eligibility vary by location and protocol.

4,584 public trials 1,037 recruiting studies
Refine in advanced search Browse all conditions

Genital Neoplasms, Female trial results

Recruiting

Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

NCT07214779

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations
  • Alaska Womens Cancer Care Akwcc Anchorage, Alaska, United States
  • University of Arizona Cancer Center Tucson, Arizona, United States
  • City of Hope Medical Center Duarte, California, United States
  • Providence Medical Foundation Fullerton, California, United States
View all 178 locations
View Trial Details
Recruiting

FOG-001 in Locally Advanced or Metastatic Solid Tumors

NCT05919264

Conditions
Adamantinomatous Craniopharyngioma, Adenocarcinoma, Adenoma, +65 more
Locations
  • Mayo Clinic Phoenix, Arizona, United States
  • Honor Health Scottsdale, Arizona, United States
  • Arizona Cancer Center at University of Arizona Tucson, Arizona, United States
  • University of California, Los Angeles (UCLA) Los Angeles, California, United States
View all 33 locations
View Trial Details
Recruiting

Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors

NCT05797168

Conditions
Adenocarcinoma, Adenocarcinoma of Lung, Adnexal Diseases, +27 more
Locations
  • Research Site Duarte, California, United States
  • Research Site Irvine, California, United States
  • Research Site La Jolla, California, United States
  • Research Site Aurora, Colorado, United States
View all 60 locations
View Trial Details
Recruiting

Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors

NCT06545942

Conditions
Adnexal Diseases, Advanced Solid Tumor, Breast Cancer, +36 more
Locations
  • Investigative Site #108 Goodyear, Arizona, United States
  • Investigative Site #101 La Jolla, California, United States
  • Investigative Site #111 San Francisco, California, United States
  • Investigative Site #104 Lake Mary, Florida, United States
View all 18 locations
View Trial Details
Recruiting

Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors

NCT07524322

Conditions
Adnexal Diseases, Advanced Breast Cancer, Breast Cancer, +30 more
Locations
  • START Los Angeles Los Angeles, California, United States
  • The University of Texas MD Anderson Cancer Center Houston, Texas, United States
  • NEXT Houston Houston, Texas, United States
  • NEXT San Antonio San Antonio, Texas, United States
View Trial Details
Recruiting

Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers

NCT03564340

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +23 more
Locations
  • University of Alabama_6th Ave Birmingham, Alabama, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dana Farber / Harvard Cancer Center Boston, Massachusetts, United States
  • Mayo Clinic - Rochester Rochester, Minnesota, United States
View all 52 locations
View Trial Details
Recruiting

A Study to Test How Well Different Doses of BI 3820768 Are Tolerated by People With Advanced Cancer (Solid Tumours)

NCT07306559

Conditions
Adnexal Diseases, Advanced Relapsed or Refractory Endometrial Cancer, Advanced Relapsed or Refractory Germ Cell Tumours, +18 more
Locations
  • Valkyrie Clinical Trials Los Angeles, California, United States
  • Indiana University Indianapolis, Indiana, United States
  • The University of Texas MD Anderson Cancer Center Houston, Texas, United States
  • Cliniques Universitaires Saint-Luc Brussels, Belgium
View all 13 locations
View Trial Details
Recruiting

DESTINY-PANTUMOUR04

NCT07124000

Conditions
Adenocarcinoma, Adenocarcinoma (NOS), Adnexal Diseases, +116 more
Locations
  • Research Site Birmingham, Alabama, United States
  • Research Site Bullhead City, Arizona, United States
  • Research Site Casa Grande, Arizona, United States
  • Research Site San Diego, California, United States
View all 18 locations
View Trial Details
Recruiting

Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer

NCT06952660

Conditions
Cervical Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +11 more
Locations
  • HonorHealth Cancer Care - Biltmore - AZCCC Imaging Phoenix, Arizona, United States
  • HonorHealth Cancer Care - Biltmore - HonorHealth Research Pharmacy Phoenix, Arizona, United States
  • HonorHealth Research Institute (Arizona Center for Cancer Care) - HonorHealth Cancer Care -Biltmore Phoenix, Arizona, United States
  • Sonora Quest Laboratories, LLC Phoenix, Arizona, United States
View all 129 locations
View Trial Details
Recruiting

A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors

NCT05208762

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +47 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of Alabama at Birmingham, IDS Pharmacy Birmingham, Alabama, United States
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of Alabama at Birmingham Birmingham, Alabama, United States
View all 62 locations
View Trial Details

Related conditions